<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02613728</url>
  </required_header>
  <id_info>
    <org_study_id>2015-0583</org_study_id>
    <secondary_id>NCI-2016-00742</secondary_id>
    <nct_id>NCT02613728</nct_id>
  </id_info>
  <brief_title>Accelerated Enhanced RECOVERy Following Minimally Invasive Colorectal Cancer Surgery (RecoverMI)</brief_title>
  <official_title>Accelerated Enhanced RECOVERy Following Minimally Invasive Colorectal Cancer Surgery (RecoverMI)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>M.D. Anderson Cancer Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>American Society of Colon and Rectal Surgeons</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>M.D. Anderson Cancer Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this clinical research study is to learn if RecoverMI care can help to shorten&#xD;
      the time that patients are in the hospital after surgery and if it can help them recover&#xD;
      sooner.&#xD;
&#xD;
      RecoverMI includes the following parts:&#xD;
&#xD;
        -  Preoperative Education&#xD;
&#xD;
        -  Early oral intake&#xD;
&#xD;
        -  Early mobilization&#xD;
&#xD;
        -  Telemedicine&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Study Groups:&#xD;
&#xD;
      If you are found to be eligible to take part in this study, you will be randomly assigned (as&#xD;
      in the flip of a coin) to 1 of 2 study groups. This is done because no one knows if one group&#xD;
      is the same, better, or worse than the other group.&#xD;
&#xD;
        -  If you are assigned to Group 1, you will receive standard enhanced care after your&#xD;
           surgery.&#xD;
&#xD;
        -  If you are assigned to Group 2, you will receive routine care after surgery, but you&#xD;
           will also receive accelerated recovery, early discharge, and Telemedicine. Participants&#xD;
           will be loaned an iPad to use for video-conferencing and text messaging in this study.&#xD;
&#xD;
      This is an investigational study. The study doctor can explain how RecoverMI is designed to&#xD;
      work.&#xD;
&#xD;
      Up to 32 participants will be enrolled in this study. All will take part at MD Anderson.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date type="Actual">May 13, 2016</start_date>
  <completion_date type="Anticipated">May 2021</completion_date>
  <primary_completion_date type="Anticipated">May 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cumulative Hospital Length of Stay (LOS)</measure>
    <time_frame>30 days post transplant</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Failure Rate (FR) in the RecoverMI Arm</measure>
    <time_frame>30 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Satisfaction</measure>
    <time_frame>30 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">32</enrollment>
  <condition>Colorectal Cancer</condition>
  <arm_group>
    <arm_group_label>Standard of Care Arm</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard enhanced care following minimally invasive colorectal cancer surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intervention (RecoverMI) Arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Routine care with Accelerated Recovery Plan, Early Discharge, and Telemedicine following minimally invasive colorectal cancer surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Accelerated Recovery Plan</intervention_name>
    <arm_group_label>Intervention (RecoverMI) Arm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Early Discharge</intervention_name>
    <arm_group_label>Intervention (RecoverMI) Arm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Telemedicine</intervention_name>
    <arm_group_label>Intervention (RecoverMI) Arm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Standard Enhanced Care</intervention_name>
    <arm_group_label>Standard of Care Arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Patient has histologically proven colorectal cancer or polyp(s) that is planned to be&#xD;
             treated by surgical resection performed with curative intent.&#xD;
&#xD;
          2. Patient is &gt;/= 18 years and younger than 80 years.&#xD;
&#xD;
          3. Elective minimally invasive operation.&#xD;
&#xD;
          4. No planned ostomy creation at time of enrollment.&#xD;
&#xD;
          5. Serum creatinine &lt;1.5 measured within 30 days of surgery.&#xD;
&#xD;
          6. Ability to speak, read, and understand English.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Strong, self-reported history of postoperative nausea and vomiting.&#xD;
&#xD;
          2. History of congestive heart failure. Systolic heart failure defined as Ejection&#xD;
             Fraction (EF) &lt;/= 40%), or diastolic heart failure defined as EF &gt;40% PLUS systemic&#xD;
             manifestation of heart failure.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>79 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>George Chang, MD, MS</last_name>
    <role>Principal Investigator</role>
    <affiliation>M.D. Anderson Cancer Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Texas MD Anderson Cancer Center</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.mdanderson.org</url>
    <description>University of Texas MD Anderson Cancer Center Website</description>
  </link>
  <verification_date>May 2019</verification_date>
  <study_first_submitted>November 23, 2015</study_first_submitted>
  <study_first_submitted_qc>November 23, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 24, 2015</study_first_posted>
  <last_update_submitted>May 10, 2019</last_update_submitted>
  <last_update_submitted_qc>May 10, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">May 14, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Colorectal cancer</keyword>
  <keyword>Colorectal cancer surgery</keyword>
  <keyword>Polyp(s)</keyword>
  <keyword>Accelerated Enhanced Recovery</keyword>
  <keyword>RecoverMI</keyword>
  <keyword>Fluid diary</keyword>
  <keyword>Questionnaires</keyword>
  <keyword>Surveys</keyword>
  <keyword>RecoverMI device</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colorectal Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

